{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/chronic-kidney-disease/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"c6b6c8c3-633d-5062-9804-7b6711e7ddcd","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field d7faa1a5-64ed-41db-b0ca-a9ff00de94c2 --><h2>How should I assess suspected chronic kidney disease?</h2><!-- end field d7faa1a5-64ed-41db-b0ca-a9ff00de94c2 -->","summary":"","htmlStringContent":"<!-- begin item 545a6d64-b89d-447e-8178-a9ff00de9456 --><!-- begin field ce338947-7235-4b44-b7f9-a9ff00de94c2 --><p><strong>If a diagnosis of chronic kidney disease (CKD) is <a class=\"topic-reference internal-reference\" href=\"/topics/chronic-kidney-disease/diagnosis/diagnosis/\">suspected</a>, assess the person for possible associated clinical features.</strong></p><ul><li><strong>Ask about:</strong><ul><li>General symptoms, such as lethargy, itch, breathlessness, cramps (often worse at night), sleep disturbance, bone pain, or loss of appetite, vomiting, weight loss, and taste disturbance (often present with end-stage disease).</li><li>Urine output, such as polyuria (tubular concentrating ability is impaired); oliguria; nocturia (due to impaired solute diuresis or oedema); or anuria (due to possible acute kidney injury [AKI], obstructive uropathy causing urinary retention; or end-stage renal disease).</li><li>Any potentially <a class=\"topic-reference internal-reference\" href=\"/topics/chronic-kidney-disease/background-information/causes/\">nephrotoxic drugs</a>, including over-the-counter or herbal medicines.</li><li>Any known <a class=\"topic-reference internal-reference\" href=\"/topics/chronic-kidney-disease/background-information/causes/\">risk factors</a> for CKD or previous history of AKI. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/acute-kidney-injury/\">Acute kidney injury</a> for more information.</li><li>Any associated co-morbidities or <a class=\"topic-reference internal-reference\" href=\"/topics/chronic-kidney-disease/background-information/complications/\">complications</a>  of CKD.</li><li>Any family history, such as autosomal dominant polycystic kidney disease.</li><li>Any associated clinical features of anxiety or depression. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a> for more information.</li></ul></li><li><strong>Examine for signs of progressive CKD, such as:</strong><ul><li>Uraemic odour (ammonia-like smell of the breath, may be present in advanced disease).</li><li>Pallor (due to <a class=\"topic-reference internal-reference\" href=\"/topics/chronic-kidney-disease/background-information/complications/\">renal anaemia</a>).</li><li>Cachexia and signs of malnutrition.</li><li>Cognitive impairment (language, orientation, and attention may be particularly affected).</li><li>Dehydration or hypovolaemia (risk of AKI). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/acute-kidney-injury/\">Acute kidney injury</a> for more information.</li><li>Tachypnoea (may be due to fluid overload, anaemia, or co-morbid ischaemic heart disease). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angina/\">Angina</a> for more information.</li><li>Hypertension (may be primary or secondary to CKD itself). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypertension-not-diabetic/\">Hypertension - not diabetic</a> for more information.</li><li>Palpable bilateral flank masses with possible hepatomegaly (suggests polycystic kidney disease with possible liver cysts).</li><li>Palpable distended bladder (suggests obstructive uropathy).</li><li>Peripheral oedema (may be due to renal sodium retention, hypoalbuminaemia, or co-morbid heart failure). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a> for more information.</li><li>Peripheral neuropathy (may present with paraesthesia, sleep disturbance, and restless legs syndrome) or myopathy. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/restless-legs-syndrome/\">Restless legs syndrome</a> for more information.</li><li>Frothy urine (may indicate proteinuria).</li></ul></li><li><strong>Arrange investigations, as appropriate.</strong> See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/chronic-kidney-disease/diagnosis/initial-investigations/\">Initial investigations</a> for more information.</li></ul><!-- end field ce338947-7235-4b44-b7f9-a9ff00de94c2 --><!-- end item 545a6d64-b89d-447e-8178-a9ff00de9456 -->","topic":{"id":"cf2598e6-fd50-5f3b-8ae0-aad8ebd19ed8","topicId":"ae266062-cc1b-44e2-8118-44e1890750e3","topicName":"Chronic kidney disease","slug":"chronic-kidney-disease","lastRevised":"Last revised in May 2020","chapters":[{"id":"5036566c-74da-5f5a-8ad0-52200f66bacc","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5b4e7fb9-e75e-5183-b93f-5121d902b8aa","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"75479619-9bb3-51b1-8d45-322a0183327c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"85bf4dec-7d92-5c07-9468-68fd460fa54c","slug":"changes","fullItemName":"Changes"},{"id":"e9caee39-e4d7-55ea-bba5-d1bfb037fab3","slug":"update","fullItemName":"Update"}]},{"id":"94be5ea4-6a52-53bd-9cff-cbc58599fb38","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"af9d912d-8cc7-598f-90cf-201a0152486f","slug":"goals","fullItemName":"Goals"},{"id":"e04a2acd-d3aa-5b29-afe8-4ff8a5cf2527","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c36c8ae1-59b3-5370-8b7b-c879c1c25d17","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1bb64e97-bb95-5733-ba72-d5da80477d5b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0cefa383-4a3f-5e37-8c1d-0cc7b2ba971c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c308ef71-7be3-579d-9b92-dd1e9164c74d","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"34f1f543-1b43-52aa-91e6-43d392ace4b2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"420f2db7-0bb3-5f08-a35d-671ffd9e83db","slug":"definition","fullItemName":"Definition"},{"id":"f36e5c98-76d5-563f-b7e3-a8e580d8edda","slug":"causes","fullItemName":"Causes"},{"id":"16745b88-79f5-5576-a0a4-704c8cb342e4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"82584375-f9fb-5690-9fe3-f2fb2586f2de","slug":"complications","fullItemName":"Complications"},{"id":"6ddacff5-19b6-5342-b340-25aecbf26dbd","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"00dbd4ad-decc-5bde-b4a3-2599d730c702","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"cdd9f22d-7a2f-5fd6-a9e1-199b0c3ffdfa","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c6b6c8c3-633d-5062-9804-7b6711e7ddcd","slug":"assessment","fullItemName":"Assessment"},{"id":"3878fa85-9973-5158-8407-20d64dbf148d","slug":"initial-investigations","fullItemName":"Initial investigations"}]},{"id":"579baee5-96e6-5639-a5ee-7dc30540dc8f","fullItemName":"Management","slug":"management","subChapters":[{"id":"07ec0bcd-8fb7-5ae7-87fd-2ff471574c5c","slug":"management-of-chronic-kidney-disease","fullItemName":"Scenario: Management of chronic kidney disease"},{"id":"44ceaa7d-a91b-5472-a7ab-e4bc448067ad","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"b0158ce5-7a78-50df-8843-ded7d59d08e3","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a270530d-7db1-5b03-a1d8-8ff38e242ab9","slug":"ace-inhibitors-aiiras","fullItemName":"ACE-inhibitors and AIIRAs"}]},{"id":"50985320-3b22-5997-85d2-680285318de6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"168ee77d-eb0d-52d8-a32b-4bda877d21f0","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c8ca80a7-ccf2-5a42-9b8e-72783e1f2131","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fe26a3ba-fa1b-5c97-8a08-e1f7d193447a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"854a26b2-4877-59ae-863e-99abcbcad667","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0af4d212-648e-5a4d-ad67-b1874a49688e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f180e32d-a855-558d-b666-d4c6804afe04","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ba009e6c-4065-55da-b6c5-bd179af81374","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"00dbd4ad-decc-5bde-b4a3-2599d730c702","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"3d2b5e04-ce95-5290-8ce7-5cd4e6363015","slug":"basis-for-recommendation-bd5","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field d14bd693-fe8b-410b-bff7-a9ff00dec9d0 --><h3>Basis for recommendation</h3><!-- end field d14bd693-fe8b-410b-bff7-a9ff00dec9d0 -->","summary":null,"htmlStringContent":"<!-- begin item bd575a28-ac6e-486c-a20d-a9ff00dec9ad --><!-- begin field e7f29115-e082-41b7-b9e7-a9ff00dec9d0 --><p>The recommendations on assessment of suspected chronic kidney disease (CKD) are based on the Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group publication <em>KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">KDIGO, 2013</a>], and expert opinion in review articles on CKD [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Fraser, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Vassalotti, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Bello, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Gaitonde, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Webster, 2017</a>].</p><h4>Assessment of symptoms</h4><ul><li>The recommendations on history-taking are based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Vassalotti, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Webster, 2017</a>].<ul><li>Over-the-counter medication such as nonsteroidal anti-inflammatory drugs (NSAIDs) and herbal medicines may be potentially nephrotoxic, and may interact with other prescribed medications to cause reduced renal function or progression of CKD.</li><li>The cause of renal itch is not fully understood, but it may be secondary to deregulation of the immune response and opioid systems.</li><li>Cramps may be due to nerve irritation caused by electrolyte disturbance seen in CKD.</li></ul></li></ul><h4>Assessment of signs</h4><ul><li>The recommendations on examination are based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Fraser, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chronic-kidney-disease/references/\">Webster, 2017</a>].<ul><li>As CKD progresses, various uraemic retention products may accumulate in multiple organs, causing a range of often non-specific symptoms and signs.</li><li>Uraemic odour is caused by the breakdown of urea by saliva.</li><li>CKD increases the risk of cognitive impairment by 65%, which may be a sign of advanced disease.</li><li>Dehydration and hypovolaemia is important to identify as it increases the risk of acute kidney injury which requires urgent management.</li></ul></li></ul><!-- end field e7f29115-e082-41b7-b9e7-a9ff00dec9d0 --><!-- end item bd575a28-ac6e-486c-a20d-a9ff00dec9ad -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}